Home Who we are Sustainability

Sustainability

We see ourselves as a business based on trust and characterised by a strong sense of responsibility.

Our ambition is to become a net zero carbon emission contributor by 2045, and we have mapped out our carbon dioxide inventory in accordance with the Greenhouse Gas Protocol and established a carbon reduction plan.

Our Sustainability Ambition: Net Zero Carbon Emissions by 2045

Our near-term carbon emission targets are:

  • Reduce absolute scope 1 and 2 emissions by 55% in fiscal year 32/33 versus 22/23 base year

  • Engage at least 67% of scope 3 suppliers (by spend) to have science-based targets by FY29/30*

Our long-term net zero target:

  • Reduce absolute scope 1, 2 and 3 emissions to achieve net zero by 2045**

*Corresponding to approximately 80% of suppliers of purchased goods & services (category 1), upstream transportation (category 4), and business travel (category 6) being covered by a supplier engagement target

**Residual 10% is allowed to be offset

Our near- and long-term goals were developed based on a carbon dioxide inventory conforming to the GHG Protocol standard and in accordance with the United Nations Paris Agreement. Pharmacosmos is committed to these goals and has established a comprehensive carbon reduction plan accordingly and will start reporting progress in our Annual Report on fiscal year 2025/26.

Our approach to sustainability

We work to protect and preserve the environment as part of our daily business operations, for example, by avoiding the use of organic solvents and cyanide traditionally used in our industry. We ensure that the environmental impact of our activities is kept to a minimum.

We focus on protecting people within our communities and work to ensure a safe and healthy working environment across all locations and functions. Our people—talented and skilled—are our most important asset at Pharmacosmos. We do not compromise on occupational health or safety.

We earn the trust and respect of patients, partners, and communities by upholding integrity and ensuring compliance. Our values—People Driven, Committed to Quality, and Innovation for Better Lives—provide us with clear guidance for our professional behavior.

We engage with partners and stakeholders, building and drawing from mutual expertise and resources to transform how iron deficiency anaemia is prevented and treated in humans and animals.

PHARMACOSMOS IS...

A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.

Who we are

As a family-held company, we are cognisant of how work shapes who we are and who we aspire to become.

Aspiration & Values

We want to change the way iron deficiency is prevented and treated.

Leadership

Being a family-owned company enables us to take a long-term view. Our leaders value long-lasting solutions rather than short-term gains.

Global presence

Our global presence is strong, thanks to our skilled colleagues and partners in all the major pharmaceutical markets. Today, we are represented in more than 40 countries. This is the key to our accelerated growth and will lay the foundation for future regional and global innovation.

Our defining moments

From a beginning in a small dairy to a state-of-the-art production facility with the capacity to meet the entire world’s demand for intravenous iron.

Code of conduct

We do not compromise on quality or business ethics, and we take action. Even when confronted with difficult situations, we make decisions that are ethically driven.